Magazine article from our research archive:
|
|
Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient
- Article from:
-
Journal of Postgraduate Medicine
- Article date:
-
July 1, 2008
- Author:
-
|
Copyright informationCopyright Medknow Publications Jul-Sep 2008. Provided by ProQuest LLC. (Hide copyright information)
|
Bisphosphonates are increasingly being incorporated in the management of patients with breast cancer. [1] With wider adoption of bisphosphonates, the incidence of some rare complications like hypocalcaemia might go up, particularly in vitamin D deficient populations. Here we would like to share our experience of managing a patient, who developed symptomatic hypocalcaemia after intravenous (IV) infusion of zoledronic acid, to highlight the need of anticipating this preventable, and potentially fatal complication.
A 70-year-old lady presented to us with right breast cancer with multiple skeletal metastases. She was put on chemotherapy along with three-weekly IV infusion of 4 mg zoledronic ...
Related newspaper, magazine, and journal articles:
|
HORIZON: Yearly infusion of zoledronic acid reduces risk of fracture in...
Formulary;
August 1, 2007 ;
700+ words
......annual intravenous (TV) infusion of zoledronic acid can decrease the risk of vertebral...Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly (HORIZON) Pivotal Fracture...receive a 1 5-minute, 5-mg infusion of zoledronic acid (n=3,889) or placebo (n=3,876) at...
|
|
|
Zometa
Formulary;
October 1, 2001 ;
427 words
...Zoledronic acid for injection NOVARTIS Short-infusion...of malignancy The bisphosphonate zoledronic acid has been approved for treatment of...double-blind, double-dummy trials comparing zoledronic acid with pamidronate in 185 patients...
|
|
Zoledronic acid for Paget's disease ranks well on cost.(Metabolic...
Family Practice News;
February 15, 2006 ;
620 words
...FT. LAUDERDALE, FLA. -- Zoledronic acid, if approved for the treatment...Pharmaceuticals Corp., the maker of zoledronic acid (Zometa). Ms. Stern, a health...act as early as this month. Zoledronic acid is administered as an intravenous...
|
|
Head-to-Head Study in The New England Journal of Medicine Finds a Single...
PR Newswire;
August 31, 2005 ;
700+ words
......the investigational bisphosphonate, zoledronic acid 5 mg solution, offers superior efficacy...compared a single 15-minute infusion of zoledronic acid 5 mg solution to oral risedronate...all patients receiving one dose of zoledronic acid 5 mg solution were effectively treated...
|
|
Zoledronic acid after hip fracture.(MINDFUL PRACTICE)
Internal Medicine News;
February 15, 2008 ;
700+ words
......however, by decreased mortality in the zoledronic acid group. Of great interest would be...once-yearly intravenous dosing with zoledronic acid. It is important to check vitamin...to the infusion. K.W. Lyles, et al. Zoledronic acid and clinical fractures and mortality...
|
|
|
New Bisphosphonate.
Internal Medicine News;
October 15, 2001 ;
16 words
...Zometa (zoledronic acid for injection) is now indicated for the treatment of hypercalcemia of malignancy.
|
|
|
Zoledronic acid lowered risk of breast ca relapse.(News)
Family Practice News;
June 15, 2008 ;
697 words
......use of endocrine therapy plus zoledronic acid (Zometa) reduced the risk of relapse...alone; tamoxifen 20 mg/day plus zoledronic acid 4 mg/every 6 months; or anastrozole 1 mg/day plus zoledronic acid 4 mg every 6 months. The study...
|
|
|
New Data Published in New England Journal of Medicine Demonstrates...
PR Newswire;
February 27, 2002 ;
700+ words
......demonstrates that the Novartis drug zoledronic acid, an intravenous bisphosphonate, significantly...10 countries, showed treatment with zoledronic acid resulted in bone mineral density increases...or one of five different doses of zoledronic acid intravenously at varying dosage ...
|
|
|
Novartis Launches First Series of Clinical Trials Evaluating Once-Yearly...
PR Newswire;
November 14, 2002 ;
700+ words
......once-yearly infusion of the Novartis drug zoledronic acid for the treatment of osteoporosis...Outcomes and Reduced Incidence with Zoledronic Acid ONce Yearly). The HORIZON program...will also evaluate a single dose of zoledronic acid given once for the treatment of Paget...
|
|
|
Zoledronic acid sustains bone in breast ca patients.(Women's Health)
Family Practice News;
February 15, 2005 ;
700+ words
...SAN ANTONIO -- Zoledronic acid prevents the profound loss in...be considered for intravenous zoledronic acid (Zometa) administered once every...conference, it was reported that zoledronic acid also effectively prevents cancer...
|
|
|
Zoledronic acid protects bone in breast Ca patients: prophylactic...
Internal Medicine News;
March 1, 2005 ;
700+ words
...SAN ANTONIO -- Zoledronic acid prevents the profound loss of...be considered for intravenous zoledronic acid (Zometa) administered once every...conference, it was reported that zoledronic acid also prevents cancer therapy-induc...
|
|
|
Single-dose zoledronic acid effective, safe in...
Internal Medicine News;
September 15, 2006 ;
486 words
...TORONTO -- A single intravenous dose of zoledronic acid reduced markers of bone resorption...a world congress on osteoporosis. Zoledronic acid is the most powerful of the available...years to a single infusion of 5 mg zoledronic acid or 70 mg weekly oral alendronate for...
|
|
New weapons in the war on osteoporosis: a wide spectrum of drug therapies...
Women's Health Advisor;
August 1, 2007 ;
700+ words
......and a new one is in the pipeline--zoledronic acid (Reclast), a once-yearly injection...to orally administered drugs. When zoledronic acid was developed as an intravenous medication...found a niche. Encouraging results Zoledronic acid is currently being reviewed by the...
|
See all results.
Or, try our
Advanced Search.
|